Target Name: USP12-DT
NCBI ID: G100874071
Review Report on USP12-DT Target / Biomarker Content of Review Report on USP12-DT Target / Biomarker
USP12-DT
Other Name(s): USP12-AS2 | USP12 divergent transcript

USP12-DT: A Potential Drug Target and Biomarker

USP12-DT, or upregulated signal phosphorylation 12, is a protein that is expressed in various tissues and cell types in the body. It is a key regulator of cell signaling pathways and has been implicated in a number of diseases, including cancer. In recent years, researchers have been interested in using USP12-DT as a potential drug target or biomarker for a variety of diseases.

The protein USP12-DT is composed of 120 amino acids and has a calculated molecular mass of 19.1 kDa. It is expressed in a variety of tissues, including the brain, heart, liver, and muscle. It is highly expressed in the brain and has been shown to be involved in the regulation of neural signaling pathways.

One of the key functions of USP12-DT is its role as a signaling molecule. It is involved in the regulation of several different signaling pathways, including the TGF-β pathway and the MAPK/ERK signaling pathway. TGF-β is a well-known signaling pathway that is involved in the regulation of cell growth, differentiation, and survival. The TGF-β pathway is a complex signaling pathway that is involved in the regulation of many different processes in the body, including cell growth, differentiation, and immune responses.

MAPK/ERK is another signaling pathway that is involved in the regulation of many different processes in the body. It is a signaling pathway that is activated in response to changes in the levels of growth factors in the body, such as tyrosine. MAPK/ERK signaling is involved in the regulation of cell growth, differentiation, and survival, as well as the regulation of many different signaling pathways that are involved in the regulation of cellular processes.

USP12-DT is involved in the regulation of both the TGF-β and MAPK/ERK signaling pathways. It has been shown to play a role in the regulation of neural stem cell proliferation and differentiation, as well as the regulation of neuronal communication. It is also involved in the regulation of the production of extracellular vesicles, which are small structures that are released from cells and play important roles in the regulation of cellular processes.

In addition to its role as a signaling molecule, USP12-DT has also been shown to have a number of different functions in the body. It is involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. It is also involved in the regulation of cell migration, which is the process by which cells move from one location in the body to another.

USP12-DT is also involved in the regulation of many different cellular processes, including cell survival and apoptosis. It has been shown to play a role in the regulation of cell cycle progression, which is the process by which cells grow and divide. It is also involved in the regulation of the production of cellular organelles, such as mitochondria and endoplasmic reticulum.

In conclusion, USP12-DT is a protein that is involved in the regulation of a number of different cellular processes in the body. It is a potential drug target and could be used as a biomarker for a variety of diseases. Further research is needed to fully understand the role of USP12-DT in the regulation of cellular processes and its potential as a drug target or biomarker.

Protein Name: USP12 Divergent Transcript

The "USP12-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about USP12-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

USP13 | USP14 | USP15 | USP16 | USP17L1 | USP17L10 | USP17L11 | USP17L12 | USP17L13 | USP17L14P | USP17L15 | USP17L17 | USP17L18 | USP17L2 | USP17L20 | USP17L21 | USP17L24 | USP17L25 | USP17L26 | USP17L27 | USP17L29 | USP17L3 | USP17L5 | USP17L6P | USP17L7 | USP17L8 | USP17L9P | USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42 | USP43 | USP44 | USP45 | USP46 | USP46-DT | USP47 | USP48 | USP49 | USP5 | USP50 | USP51 | USP53 | USP54 | USP6 | USP6NL | USP6NL intronic transcript 1 (non-protein coding), transcript variant 1 | USP7 | USP8 | USP8P1 | USP9X | USP9Y | USPL1 | UST | UTF1 | UTP11 | UTP14A | UTP14C | UTP15 | UTP18 | UTP20 | UTP23 | UTP25 | UTP3 | UTP4 | UTP6 | UTRN | UTS2 | UTS2B | UTS2R